Orexigen Therapeutics, Inc. (NASDAQ:OREX) Reported Basic Consolidated EPS Of $-5.2381 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Orexigen Therapeutics, Inc. (NASDAQ:OREX) for the period ended 2015-12-31 was $-5.2381. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-5.2381.

EPS from continuing operations

Coming to basic EPS from continuing operations, Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported $-5.2381 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-5.2381.

EPS contribution from parent

For the annual period ended 2015-12-31, Orexigen Therapeutics, Inc. (NASDAQ:OREX) received basic EPS of $-5.2381 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-5.2381.

Basic net EPS

For the annual period ended 2015-12-31, Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported basic net EPS of $-5.2. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-5.2.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-5.2381. For the quarter ended 2015-12-31, consolidated diluted EPS was $-5.2381.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-5.2381 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-5.2381.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-5.2. For the quarterly period ended 2015-12-31, net diluted EPS was $-5.2.

Diluted EPS from parent

From the parent company, Orexigen Therapeutics, Inc. (NASDAQ:OREX) received diluted EPS of $-5.2381 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-5.2381.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) posted net basic EPS reading of $-5.2 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-5.2 was for the quarter ended 2015-12-31.

Net diluted EPS for Orexigen Therapeutics, Inc. (NASDAQ:OREX) for the annual period ended 2015-12-31 was $-5.2. The company also reported net diluted EPS reading of $-5.2 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 13.113 while for the quarter ended 2015-12-31 is 13.113.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 13.113 while for the quarter ended 2015-12-31 is 13.113.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 29 times, 1 visits today)